Now Available: Spotlight on Alamar Biosciences CEO Yuling Luo. Click here to read.
Today, we are proud to announce that we have raised $60 million in a Series C financing — just more than a year after our Series B close. In addition, we have acquired GeneMatters, a leading telehealth genetic counseling and software solutions company, and we welcome their team to the Genome Medical family.
Virtual health-care startup LetsGetChecked has raised $150 million in new financing to expand its business after seeing a boom in demand for its services during the pandemic. The funding round, which was led by Casdin Capital, valued the startup at more than $1 billion, Chief Executive Officer Peter Foley said in an interview. Other investors included CommonFund Capital, Illumina Ventures, Optu...
Delfi Diagnostics, Inc., a pioneering developer of a new class of high performance, affordable liquid biopsy tests for early cancer detection, has raised $100 million in Series A funding. {Illumina Ventures participated in the round.} Delfi plans to use this round of funds to expand its team of cancer researchers and machine learning experts and to validate its novel next-generation liquid bio...
Rebus Biosystems, Inc., a life science technology company building innovative tools to enable spatial omics without compromise, today announced the closing of a $20 million Series B financing round, led by Illumina Ventures...“We are excited to support Rebus Biosystems’ mission to bring powerful new spatial omics tools and assays to market,” said Tom Willis, Partner at Illumina Ventures. “The a...
Your screen does not meet the requirements for generating previews. Adjust your screen width to exactly 1920px before proceeding, otherwise you'll not be able to generate previews.
